Issue Date: December 19, 2016
A two-punch attack from CRISPR knocks out HIV in cells
When HIV infects a person, the virus integrates its DNA into the genomes of the person’s immune system cells. Daily doses of antiretroviral drugs suppress replication of that viral DNA, but it’s not a cure.
“An ideal situation would be a single treatment, rather than lifelong therapy,” says Atze T. Das of the University of Amsterdam. In a new study, Das and colleagues report progress on a possible one-time therapy. They permanently inactivated HIV in . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society